FTSE 100

Key insight

The 11,000-point level is the defining near-term battleground — a clean break above it would open up all-time high territory and trigger momentum-driven inflows, while a failure to breach it risks a reversion toward the 10,700 200-day MA zone.

The FTSE 100 is extending a three-session winning streak at 10,909.70, closing in on the historic 11,000-point psychological resistance milestone, driven by strong corporate earnings from Admiral and Persimmon and easing Middle East geopolitical risk.

Main risk

AstraZeneca Merger Speculation & HSBC/Prudential Asia Drag

AstraZeneca, one of the index's largest components, fell over 6% on Bristol Myers Squibb merger rumours, and HSBC/Prudential remain under pressure from Asia-Pacific macro headwinds — combined, these heavyweights could cap or reverse index gains despite the broader positive tape.